Buscar
01/05/2023
Gestational weight gain and pregnancy outcomes in women with type 1 and type 2 diabetes mellitus
Xie X., Liu J., García-Patterson A., Chico A., Mateu-Salat M., Amigó J., Adelantado J.M., Corcoy R.. Gestational weight gain and pregnancy outcomes in women with type 1 and type 2 diabetes mellitus. ACTA DIABETOLOGICA. 2023; 60(5)DOI:10.1007/s00592-023-02031-0. PMID:36707439. IF:3.100(Q2/5D).
01/05/2023
Research Priorities for Precision Medicine in NAFLD
Iruzubieta, P, Bataller, R, Arias-Loste, MT, Arrese, M, Calleja, JL, Castro-Narro, G, Cusi, K, Dillon, JF, Martinez-Chantar, ML, Mateo, M, Perez, A, Rinella, ME, Romero-Gomez, M, Schattenberg, JM, Zelber-Sagi, S, Crespo, J, Lazarus, JV. Research Priorities for Precision Medicine in NAFLD. Clinics in Liver Disease. 2023; 27(2)DOI:10.1016/j.cld.2023.01.016. PMID:37024222. IF:2.900(Q2/5D).
01/05/2023
The Good Life From Birth to Death
Paff, SM, Olives, MG, Zaragoza, BC, Porcel, MA, Fernandez, AR, Serret, MS, Abal, ER. The Good Life From Birth to Death. Holistic Nursing Practice. 2023; 37(3)DOI:10.1097/HNP.0000000000000582. PMID:37070837. IF:1.300(Q3/6D).
01/05/2023
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
Remon, J, Besse, B, Aix, SP, Callejo, A, Al-Rabi, K, Bernabe, R, Greillier, L, Majem, M, Reguart, N, Monnet, I, Cousin, S, Garrido, P, Robinet, G, Campelo, RG, Madroszyk, A, Mazieres, J, Curcio, H, Wasag, B, Pretzenbacher, Y, Fournier, B, Dingemans, AMC, Dziadziuszko, R. Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial. ANNALS OF ONCOLOGY. 2023; 34(5)DOI:10.1016/j.annonc.2023.02.012. PMID:36863484. IF:56.700(Q1/1D).